1. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus. (13th July 2016) Authors: Garabet, L.; Gilboe, I.‐M.; Mowinckel, M.‐C.; Jacobsen, A. F.; Mollnes, T. E.; Sandset, P. M.; Jacobsen, E.‐M. Journal: Scandinavian journal of immunology Issue: Volume 84:Number 2(2016:Aug.) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1684: NO INCREASE IN THROMBIN GENERATION OR D-DIMER LEVELS AFTER ANTI-SARS-COV-2 VACCINES INCLUDING IN THOSE WITH ANTI-PLATELET FACTOR 4 ANTIBODIES. (23rd June 2022) Authors: Garabet, L.; Eriksson, A.; Tjønnfjord, E.; Kringstad Olsen, M.; Jacobsen, H. K.; Tøvik Jørgensen, C.; Mathisen, Å.-B.; Mowinckel, M.-C.; Ahlen, M. T.; Hausberg Sørvoll, I.; Daae Horvei, K.; Leiknes Ernstsen, S.; Jenssen Lægreid, I.; Sandset, P. M.; Ghanima, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1697: EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE TINA-QUANT D-DIMER GEN. 2 IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS. (23rd June 2022) Authors: Tonne, B.; Pedersen, M. H.; Fronas, S. G.; Jorgensen, C. T.; Mathisen, A.-B.; Ghanima, W.; Garabet, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB2300: COMPLEMENT ACTIVATION NEGATIVELY AFFECTS THE PLATELET RESPONSE TO THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY. (23rd June 2022) Authors: Åkesson, A.; Bussel, J. B.; Martin, M.; Blom, A. M.; Klintman, J.; Ghanima, W.; Zetterberg, E.; Garabet, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗